Parkinson syndrome--a contribution on current drug therapy
Völler, G.W.
Medizinische Monatsschrift für Pharmazeuten 2(2): 33-40
1979
ISSN/ISBN: 0342-9601 PMID: 554935 Document Number: 150760
Document emailed within 1 workday
Related Documents
Christiani, K.; Möller, W.D. 1973: Drug therapy of Parkinson's syndrome. Clinical long-term study using L-dopa and the drug conbination L-dopa-decarboxylase inhibitor Münchener Medizinische Wochenschrift 115(16): 711-713Llau, M.E.; Nguyen, L.; Senard, J.M.; Rascol, O.; Montastruc, J.L. 1994: Drug-induced Parkinson syndrome: 10 years of drug vigilance Therapie 49(5): 459-460
Fischer, P.A. 1983: Drug treatment of Parkinson syndrome Die Medizinische Welt 34(7): 220-221
Oehme, P.; Brüschke, G.; Kluchert, K.; Krüger, U. 1970: Current problems of drug therapy. 9. Stationary and ambulatory drug therapy. 2 Das Deutsche Gesundheitswesen 25(21): 957-960
Nikitin, I.P.; Leopa, N.A. 1979: Wolff-Parkinson-White syndrome (WPW) and current approaches to diagnosis and treatment Kardiologiia 19(7): 110-115
Lukoshevichiute, A.I.; Reĭngardene, D.I. 1981: Value of drug tests in Wolff-Parkinson-White syndrome Kardiologiia 21(10): 113-116
Gehlen, W. 1980: Adverse effects of drug therapy in Parkinson disease Medizinische Monatsschrift für Pharmazeuten 3(4): 104-110
Clarenbach, P.; Fröscher, W. 1986: Therapy of Parkinson syndrome Fortschritte der Medizin 104(44): 857-861
Gladtke, E. 1981: Current problems in drug therapy in children. Drug interactions, age-dependent changes in pharmacokinetic data, recommendations for dosage Die Medizinische Welt 32(7): 219-224
Umbach, W. 1970: Classification and therapy of the Parkinson syndrome Deutsche Medizinische Wochenschrift 95(1): 44-45
Bermejo, F.; Martínez, P.; de Yébenes, J.G. 1986: Parkinson disease, adverse effects of chronic levodopa therapy and drug holidays Archivos de Neurobiologia 49(5): 300-302
Ludin, H.P. 1984: Long-term therapy of the Parkinson syndrome Schweizerische Medizinische Wochenschrift 114(33): 1131-1136
Lombardo, L. 1974: Recent advances in the therapy of Parkinson's syndrome Gaceta Medica de Mexico 107(6): 513-524
Staner, L. 1992: The practice of electroconvulsive therapy: current contribution. II.--administration and evaluation of treatment Acta Psychiatrica Belgica 92(1): 33-48
So, C.S. 1978: Arrhythmia. Diagnosis and therapy. WPW (Wolff-Parkinson-White)syndrome i Medizinische Klinik 73(49): Preceding 1731
So, C.S. 1979: Arrhythmias. Diagnosis and therapy. WPW (Wolff-Parkinson-White)-syndrome Vi Medizinische Klinik 74(7): Preceding 229
So, C.S. 1978: Arrhythmias. Diagnosis and therapy. WPW (Wolff-Parkinson-White) syndrome II Medizinische Klinik 73(51-52): Preceding 1809
Fischer, P.A.; Schneider, E.; Jacobi, P.; Maxion, H. 1973: Combination therapy of Parkinson's syndrome using L-dopa and a decarboxylase inhibitor Die Medizinische Welt 24(45): 1742-1746
Zakrzewska, F. 1970: Hoffmann's monosynaptic reflex (H) and direct motor response (M) from the tonic and phasic muscles in drug-induced Parkinson's syndrome Neurologia i Neurochirurgia Polska 4(2): 159-168
Gospavić, J.; Vidaković, Z. 1974: Effectiveness of a combination therapy in the Parkinson syndrome by amantadine hydrochloride and anticholinergic agents Srpski Arhiv Za Celokupno Lekarstvo 102(6): 447-457